Saracatinib-d3
Saracatinib-d3 (AZD0530-d3) (ZG5129) is the deuterium-labeled analog of Saracatinib (HY-10234) . Saracatinib-d3 is an inhibitor of the Src kinase, which can inhibit severe sepsis caused by bacterial or various microbial infections[1].
Product Specifications
CAS Number
[2200301-36-4]
Product Name Alternative
AZD0530-d3
UNSPSC
12352005
Target
Src
Type
Isotope-Labeled Compounds
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
[2H]C([2H])([2H])N(CC1)CCN1CCOC2=CC3=C(C(OC4CCOCC4)=C2)C(NC5=C6C(OCO6)=CC=C5Cl)=NC=N3
Molecular Formula
C27H29D3ClN5O5
Molecular Weight
545.04
References & Citations
[1]Anning Lin. TREATMENT OF TNF-alpha CYTOTOXICITY. Patent WO2018045258, 2018-03-08.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CO486a 1 Each
Colon cancer tissue array with normal colon tissue as control, including pathology grade, TNM and clinical stage, 48 cases/48 cores, core size 2.0 mm.
Ask
View Details 
MBS6334532-01 0.2 mL
PLA2G2C, CT (PLA2G2C, Putative inactive group IIC secretory phospholipase A2, Phosphatidylcholine 2-acylhydrolase-like protein GIIC) (APC)
Ask
View Details